SugarCone Biotech will provide a novel targets overview at the Immunomodulatory Antibodies for Cancer conference taking place tomorrow and Tuesday, August 11-12,  at the Marriott Long Wharf Hotel in Boston.

I’ll highlight some of our favorite novel targets during my talk entitled The Next Wave of Immune Checkpoint Targets, at 2pm on August 11th.

Also, I’ll be live tweeting the conference which also features Michael Postow from Memorial Sloan Kettering Cancer Center, Vijay Kuchroo from Harvard Medical School, Dmitry Gabrilovich from the Wistar Institute, Agenus, Peregrine Pharmaceuticals, Compugen, F-star, Pelican Therapeutics, Lion Biotechnologies, Quest Pharmatech, arGen-X and other academic groups and biotechs.

I’ve been told you can register at the door (ask for the discount registration!) and just walk on in, or go to http://www.imvacs.com/Immunomodulatory-Antibodies-Cancer/ for more information.

Finally, follow me @PDRennert for updates throughout the day tomorrow and Tuesday.